Typically, SRC-mediated p27 phosphorylation impairs the Cdk2 inhibitory action of p27 and thereby promotes the tamoxifen-resistance in BC cells, as well as the tumor progression in a mouse BC model [107, 108]. The gene discussed is SRC; the disease is breast cancer.